Who is sponsoring THUNDER?

THUNDER is sponsored by Novartis Pharmaceuticals.

What drugs are being tested in THUNDER?

Interventions: Fevipiprant 150 mg, Fevipiprant 450 mg, Placebo.

What is the status of THUNDER?

THUNDER is currently COMPLETED.

Last reviewed 2021-10-11 · How we verify

Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma (THUNDER)

NCT03681093 PHASE3 COMPLETED Results posted

A Phase 3b Proof-of-Concept study to evaluate the ability of fevipiprant 150 mg and 450 mg, compared with placebo, as add-on to nasal spray standard-of-care (SoC), in reducing endoscopic nasal polyp score in adult (≥ 18 years) patients with nasal polyposis and concomitant asthma.

Details

Lead sponsor	Novartis Pharmaceuticals
Phase	PHASE3
Status	COMPLETED
Enrolment	98
Start date	Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Jun 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Nasal Polyps

Interventions

Fevipiprant 150 mg
Fevipiprant 450 mg
Placebo

Countries

Italy, Netherlands, Belgium, Germany, Poland, Argentina, Canada, United States, Czechia